These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1409 related items for PubMed ID: 8325947
1. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys. Stouffer RL, Woodruff TK, Dahl KD, Hess DL, Mather JP, Molskness TA. J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947 [Abstract] [Full Text] [Related]
2. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys. Molskness TA, Woodruff TK, Hess DL, Dahl KD, Stouffer RL. J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851 [Abstract] [Full Text] [Related]
3. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function. Stouffer RL, Hodgen GD, Ottobre AC, Christian CD. J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256 [Abstract] [Full Text] [Related]
7. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function. Zelinski-Wooten MB, Lanzendorf SE, Wolf DP, Chandrasekher YA, Stouffer RL. J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481 [Abstract] [Full Text] [Related]
8. Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Stouffer RL, Dahl KD, Hess DL, Woodruff TK, Mather JP, Molskness TA. Biol Reprod; 1994 Apr; 50(4):888-95. PubMed ID: 8199268 [Abstract] [Full Text] [Related]
9. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles. Zelinski-Wooten MB, Hutchison JS, Chandrasekher YA, Wolf DP, Stouffer RL. J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951 [Abstract] [Full Text] [Related]
10. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone. Stouffer RL, Hodgen GD, Graves PE, Danforth DR, Eyster KM, Ottobre JS. J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556 [Abstract] [Full Text] [Related]
11. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat. Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH. J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896 [Abstract] [Full Text] [Related]
12. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion. Suresh PS, Medhamurthy R. Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529 [Abstract] [Full Text] [Related]
13. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA. Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355 [Abstract] [Full Text] [Related]
14. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle. Grimes EM, Thompson IE, Taymor ML. Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349 [Abstract] [Full Text] [Related]
15. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH. Faure N, Olivier GC. Horm Res; 1978 Aug; 9(1):12-21. PubMed ID: 338460 [Abstract] [Full Text] [Related]
16. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions. Heikinheimo O, Gordon K, Williams RF, Hodgen GD. Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191 [Abstract] [Full Text] [Related]
17. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR. J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862 [Abstract] [Full Text] [Related]
18. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. Schipper I, Hop WC, Fauser BC. J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158 [Abstract] [Full Text] [Related]
19. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM, Nestor JJ, Vickery BH. Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [Abstract] [Full Text] [Related]
20. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS. J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]